Absorption of quinidine from an enteric-coated preparation. 1979

D Fremstad, and O G Nilsen, and J Amlie, and L Storstein, and B Olsson, and S Jacobsen

The absorption of quinidine from single and multiple doses of an enteric-coated preparation (Systodin) was studied in seven healthy subjects, and was compared with the pharmacokinetics of intravenously administered quinidine and the results of in vitro dissolution tests of the tablets. Absorption of quinidine began after a variable delay, 2-8 h (mean 4.8) after fasting and 3-10 h (mean 6.1) after food. The rate of absorption varied both in and between individuals. It appeared to be lower when the drug was administered after food. Multiple doses after food gave a pattern of plasma concentration-time curves similar to that found on administration of single doses after food. The delay prior to absorption was prolonged at night. The ratio between the maximum and minimum concentration of quinidine during a dose interval varied from 1.3 to 3.2 (mean 2.0). Bioavailability of quinidine in fasting subjects ranged from 69 to 95% (mean 83); variation was greater when doses were administered after food. The release of quinidine from the enteric-coated preparation was pH dependent and was sustained at low pHs as may be found in the intestines. The results indicate that the absorption of quinidine from the enteric-coated formulation was dependent on the highly variable rate of gastric emptying and the pH of intestinal fluid, and it varied greatly both within and between individuals.

UI MeSH Term Description Entries
D007408 Intestinal Absorption Uptake of substances through the lining of the INTESTINES. Absorption, Intestinal
D008297 Male Males
D011802 Quinidine An optical isomer of quinine, extracted from the bark of the CHINCHONA tree and similar plant species. This alkaloid dampens the excitability of cardiac and skeletal muscles by blocking sodium and potassium currents across cellular membranes. It prolongs cellular ACTION POTENTIALS, and decreases automaticity. Quinidine also blocks muscarinic and alpha-adrenergic neurotransmission. Adaquin,Apo-Quinidine,Chinidin,Quincardine,Quinidex,Quinidine Sulfate,Quinora,Apo Quinidine,Sulfate, Quinidine
D005215 Fasting Abstaining from FOOD. Hunger Strike,Hunger Strikes,Strike, Hunger,Strikes, Hunger
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities
D013608 Tablets, Enteric-Coated Tablets coated with material that delays release of the medication until after they leave the stomach. (Dorland, 28th ed) Enteric-Coated Tablets,Tablets, Enteric Coated

Related Publications

D Fremstad, and O G Nilsen, and J Amlie, and L Storstein, and B Olsson, and S Jacobsen
February 1976, Australian and New Zealand journal of medicine,
D Fremstad, and O G Nilsen, and J Amlie, and L Storstein, and B Olsson, and S Jacobsen
June 2001, Methods and findings in experimental and clinical pharmacology,
D Fremstad, and O G Nilsen, and J Amlie, and L Storstein, and B Olsson, and S Jacobsen
January 1966, Acta pharmacologica et toxicologica,
D Fremstad, and O G Nilsen, and J Amlie, and L Storstein, and B Olsson, and S Jacobsen
January 1983, JAMA,
D Fremstad, and O G Nilsen, and J Amlie, and L Storstein, and B Olsson, and S Jacobsen
June 1979, British medical journal,
D Fremstad, and O G Nilsen, and J Amlie, and L Storstein, and B Olsson, and S Jacobsen
June 1979, British medical journal,
D Fremstad, and O G Nilsen, and J Amlie, and L Storstein, and B Olsson, and S Jacobsen
December 1979, Digestive diseases and sciences,
D Fremstad, and O G Nilsen, and J Amlie, and L Storstein, and B Olsson, and S Jacobsen
August 1975, British journal of clinical pharmacology,
D Fremstad, and O G Nilsen, and J Amlie, and L Storstein, and B Olsson, and S Jacobsen
April 2020, The Indian journal of medical research,
D Fremstad, and O G Nilsen, and J Amlie, and L Storstein, and B Olsson, and S Jacobsen
May 1994, Pharmaceutical research,
Copied contents to your clipboard!